These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30939273)

  • 21. Drug-induced torsade de pointes.
    Trohman RG; Sahu J
    Circulation; 1999 Apr; 99(16):E7. PubMed ID: 10217665
    [No Abstract]   [Full Text] [Related]  

  • 22. Ibutilide as a Torsade de Pointes Stress Test.
    Reiffel JA
    J Am Coll Cardiol; 2016 Jun; 67(23):2806. PubMed ID: 27282905
    [No Abstract]   [Full Text] [Related]  

  • 23. Amiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia.
    Tran HT; Chow MS; Kluger J
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2275-8. PubMed ID: 9309756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and cost analysis of ibutilide.
    Dunn AB; White CM; Reddy P; Chow MS; Kluger J
    Ann Pharmacother; 2000 Nov; 34(11):1233-7. PubMed ID: 11098333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced QT prolongation in women during the menstrual cycle.
    Rodriguez I; Kilborn MJ; Liu XK; Pezzullo JC; Woosley RL
    JAMA; 2001 Mar; 285(10):1322-6. PubMed ID: 11255387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsade de pointes.
    Campens D
    Anesth Analg; 1996 Oct; 83(4):887. PubMed ID: 8831345
    [No Abstract]   [Full Text] [Related]  

  • 27. In-hospital monitoring of T-wave alternans in a case of amiodarone-induced torsade de pointes: clinical and methodologic insights.
    Kawaguchi T; Takasugi N; Kubota T; Takasugi M; Kanamori H; Ushikoshi H; Hattori A; Aoyama T; Kawasaki M; Nishigaki K; Takemura G; Minatoguchi S; Verrier RL
    Europace; 2012 Sep; 14(9):1372-4. PubMed ID: 22389418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinidine cardiotoxicity.
    Tsai CL
    J Emerg Med; 2005 May; 28(4):463-5. PubMed ID: 15837031
    [No Abstract]   [Full Text] [Related]  

  • 29. Sotalol-induced torsades de pointes precipitated during treatment with oseltamivir for H1N1 influenza.
    Wells Q; Hardin B; Raj SR; Darbar D
    Heart Rhythm; 2010 Oct; 7(10):1454-7. PubMed ID: 20656063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Torsade de pointes induced by ajmaline.
    Haverkamp W; Mönnig G; Kirchhof P; Eckardt L; Borggrefe M; Breithardt G
    Z Kardiol; 2001 Aug; 90(8):586-90. PubMed ID: 11565214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Torsade de pointes occurring early during oral amiodarone treatment.
    Faggiano P; Gardini A; D'Aloia A; Benedini G; Giordano A
    Int J Cardiol; 1996 Jul; 55(2):205-8. PubMed ID: 8842793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome.
    Badshah A; Mirza B; Janjua M; Nair R; Steinman RT; Cotant JF
    Hellenic J Cardiol; 2009; 50(3):224-6. PubMed ID: 19465366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Torsade de pointes and QT syndrome].
    Haverkamp W; Hördt M; Borggrefe M; Breithardt G
    Med Klin (Munich); 1995 Apr; 90(4):240-5. PubMed ID: 7776938
    [No Abstract]   [Full Text] [Related]  

  • 34. Practice and challenges of thorough QT studies.
    Stockbridge N; Zhang J; Garnett C; Malik M
    J Electrocardiol; 2012; 45(6):582-7. PubMed ID: 22999322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Torsade de pointes.
    Bubien R
    Am J Nurs; 1999 Sep; 99(9):36-7. PubMed ID: 10489578
    [No Abstract]   [Full Text] [Related]  

  • 36. Refractory torsade de pointes induced by terlipressin (Glypressin).
    Jao YTFN
    Int J Cardiol; 2016 Nov; 222():135-140. PubMed ID: 27494726
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-induced torsade de pointes arrhythmias in the chronic AV block dog are perpetuated by focal activity.
    Boulaksil M; Jungschleger JG; Antoons G; Houtman MJ; de Boer TP; Wilders R; Beekman JD; Maessen JG; van der Hulst FF; van der Heyden MA; van Veen TA; van Rijen HV; de Bakker JM; Vos MA
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):566-76. PubMed ID: 21622813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
    Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA
    J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
    Silvetti MS; Drago F; Bevilacqua M; Ragonese P
    Ital Heart J; 2001 Mar; 2(3):231-6. PubMed ID: 11305536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale.
    Nagra BS; Ledley GS; Kantharia BK
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):191-5. PubMed ID: 16211208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.